These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25415148)

  • 1. Effects of polyunsaturated fatty acids on periprocedural myocardial infarction after elective percutaneous coronary intervention.
    Suzuki A; Ando H; Takashima H; Kumagai S; Kurita A; Waseda K; Suzuki Y; Mizuno T; Harada K; Uetani T; Takahashi H; Yoshikawa D; Ishii H; Murohara T; Amano T
    EuroIntervention; 2014 Nov; 10(7):792-8. PubMed ID: 25415148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
    Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
    J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
    Zeng RX; Li XL; Zhang MZ; Guo YL; Zhu CG; Guo LH; Li S; Zhang Y; Li JJ
    Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention.
    Buturak A; Degirmencioglu A; Erturk M; Karakurt H; Demir AR; Surgit O; Pusuroglu H; Akgul O; Serteser M; Norgaz T; Gorgulu S
    Coron Artery Dis; 2015 Jun; 26(4):333-40. PubMed ID: 25714068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention.
    Harada K; Kikuchi R; Suzuki S; Tanaka A; Aoki T; Iwakawa N; Kojima H; Hirayama K; Mitsuda T; Sumi T; Negishi Y; Ishii H; Murohara T
    Lipids Health Dis; 2018 Feb; 17(1):21. PubMed ID: 29391013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
    BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study.
    Takahashi M; Ando J; Shimada K; Nishizaki Y; Tani S; Ogawa T; Yamamoto M; Nagao K; Hirayama A; Yoshimura M; Daida H; Nagai R; Komuro I
    BMC Cardiovasc Disord; 2017 Jan; 17(1):41. PubMed ID: 28125968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
    Zhong Z; Liu J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Med Sci Monit; 2018 Jun; 24():4154-4161. PubMed ID: 29910459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
    J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in the eicosapentaenoic acid-arachidonic acid ratio associated with age in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Nakabayashi K; Jujo K; Furuki Y; Ishida I; Ando H; Shimizu M; Hagiwara N; Saito K
    Heart Vessels; 2019 May; 34(5):755-762. PubMed ID: 30430295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyunsaturated Fatty Acid Impact on Clinical Outcomes in Acute Coronary Syndrome Patients With Dyslipidemia: Subanalysis of HIJ-PROPER.
    Arashi H; Yamaguchi J; Kawada-Watanabe E; Koyanagi R; Sekiguchi H; Mori F; Haruta S; Ishii Y; Murasaki S; Suzuki K; Yamauchi T; Ogawa H; Hagiwara N
    J Am Heart Assoc; 2019 Aug; 8(16):e012953. PubMed ID: 31390907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum laboratory parameters with periprocedural myocardial infarction after a primary percutaneous coronary intervention.
    Deng Q; Hou J; Deng X; Zhong Z
    Perfusion; 2023 Mar; 38(2):393-400. PubMed ID: 35038275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Bressi E; Mangiacapra F; Ricottini E; Cavallari I; Colaiori I; Di Gioia G; Creta A; Di Sciascio G
    Am J Cardiol; 2016 Oct; 118(7):980-4. PubMed ID: 27515894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention.
    Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
    J Clin Lipidol; 2014; 8(4):423-32. PubMed ID: 25110224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of non-cardiac biomarkers with periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.
    Zeng RX; Li JJ; Liao PD; Zhang MZ
    Int J Cardiol; 2016 Oct; 221():726-33. PubMed ID: 27428312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
    Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
    Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention.
    Kang MG; Kang Y; Jang HG; Kim K; Koh JS; Park JR; Hwang SJ; Hwang JY; Bae JS; Ahn JH; Jang JY; Park Y; Jeong YH; Kwak CH; Park HW
    Coron Artery Dis; 2018 Nov; 29(7):589-596. PubMed ID: 29965838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.